Advertisement
Screener

Marqeta, Inc. (MQ) Equity Method Investment, Other than Temporary Impairment

2.1 / 5 stars · 16/38 Roast Me

Marqeta, Inc. Equity Method Investment, Other than Temporary Impairment

Marqeta, Inc. (MQ) reported Equity Method Investment, Other than Temporary Impairment of $11.60 million for the 12-month period ending 2023-12-31, per its 10-K filed 2025-02-26.

Financial Statements › Income Statement › Other Income

us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2025-02-26

  • Marqeta, Inc. equity method investment, other than temporary impairment for the quarter ending 2022-12-31 was $0.00.
  • Marqeta, Inc. equity method investment, other than temporary impairment for the quarter ending 2022-09-30 was $0.00.
  • Marqeta, Inc. equity method investment, other than temporary impairment for the quarter ending 2022-06-30 was $0.00.
  • Marqeta, Inc. equity method investment, other than temporary impairment for the quarter ending 2022-03-31 was $11.60M.
  • Marqeta, Inc. equity method investment, other than temporary impairment for fiscal 2023 was $11.60M, a 0.00% change from fiscal 2022.
  • Marqeta, Inc. equity method investment, other than temporary impairment for fiscal 2022 was $11.60M.
Period endEquity Method Investment, Other than Temporary Impairment 3 monthEquity Method Investment, Other than Temporary Impairment 6 monthEquity Method Investment, Other than Temporary Impairment 9 monthEquity Method Investment, Other than Temporary Impairment 12 month
2023-12-31$11.60M
10-K · filed 2025-02-26
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$0.00
derived: sum of 2 quarters · filed 2024-02-28
$0.00
derived: sum of 3 quarters · filed 2024-02-28
$11.60M
10-K · filed 2024-02-28
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$11.60M
10-Q · filed 2022-11-09
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$11.60M
10-Q · filed 2022-08-10
2022-03-31$11.60M
10-Q · filed 2022-05-11